RhumbLine Advisers’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.6K | Buy |
22,336
+3,183
| +17% | +$7.35K | ﹤0.01% | 3665 |
|
|
2025
Q1 | $150K | Buy |
19,153
+2,409
| +14% | +$18.8K | ﹤0.01% | 3250 |
|
|
2024
Q4 | $78.2K | Buy |
16,744
+2,424
| +17% | +$11.3K | ﹤0.01% | 3545 |
|
|
2024
Q3 | $77.2K | Buy |
14,320
+547
| +4% | +$2.95K | ﹤0.01% | 3584 |
|
|
2024
Q2 | $121K | Buy |
+13,773
| New | +$121K | ﹤0.01% | 3457 |
|